AI-Powered Predictive Analytics for Early Detection of Cardiovascular Diseases

Abstract

Cardiovascular diseases (CVDs) remain the foremost cause of morbidity and mortality worldwide, accounting for an estimated 18 million deaths annually. Early identification of individuals at high cardiovascular risk is crucial for reducing disease burden and improving clinical outcomes. Traditional statistical models such as the Framingham Risk Score and ASCVD calculator, while useful for population-level screening, often fail to capture the complex, nonlinear relationships and temporal patterns underlying disease progression. In recent years, artificial intelligence (AI) and machine learning (ML) have transformed cardiovascular risk prediction by enabling large-scale integration of multimodal data—including electronic health records, imaging modalities, genomic signatures, proteomics, wearable sensors, and behavioral indicators.

This review explores the evolving landscape of AI-powered predictive analytics for early CVD detection. It discusses the types of data used, model architectures, performance metrics, validation approaches, and translational challenges. Emphasis is placed on deep learning methods such as convolutional, recurrent, and transformer networks, as well as ensemble and explainable AI (XAI) frameworks that enhance model transparency and trustworthiness. The paper further examines key applications across coronary artery disease, heart failure, atrial fibrillation, and hypertension, demonstrating how multimodal fusion can improve diagnostic precision and clinical decision-making.

Despite rapid advances, substantial challenges persist—data heterogeneity, privacy concerns, limited external validation, algorithmic bias, and the lack of regulatory clarity impede clinical deployment. Moving forward, collaborative frameworks incorporating federated learning, equity auditing, and regulatory-standard validation will be critical to transforming AI-driven prediction into real-world preventive cardiology. Ultimately, integrating interpretable AI into clinical workflows could redefine how cardiovascular disease is anticipated, managed, and prevented in the era of precision medicine.